Ranbaxy puts biosimilars into gear

(Reuters) - Ranbaxy Laboratories Ltd will launch at least three copies of biotech medicines in India by 2015, mostly to treat cancer, and needs to develop such high-tech drugs to remain a serious player in the global generics business, Chief Executive Arun Sawhney said on Tuesday.

used homeschool books homeschool preschool sonlight curriculum reviews